kamn-20230905
0000054381false00000543812023-09-052023-09-05

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported):September 5, 2023
https://cdn.kscope.io/f884917c47948d4a5acbbab314e9a34e-Capture logo.jpg
KAMAN CORPORATION
(Exact name of registrant as specified in its charter)
Connecticut001-3541906-0613548
(State or Other Jurisdiction of Incorporation)(Commission File Number)(IRS Employer Identification No.)
1332 Blue Hills Avenue,Bloomfield,Connecticut06002
(Address of principal executive offices)(Zip Code)
(860) 243-7100
(Registrant’s telephone number, including area code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock ($1 par value per share)KAMNNew York Stock Exchange LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.







Item 7.01 Regulation FD Disclosure.

From time to time, members of the Company's senior management present information about the Company to investors. A copy of an investor presentation dated September 5, 2023 is attached as Exhibit 99.1.

The information in this Item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section and shall not be deemed incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01    Financial Statements and Exhibits.

(d)    Exhibits

The following exhibits are filed with this report:
Exhibit Description
99.1
104Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document




SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

KAMAN CORPORATION
By:/s/ Carroll Lane
Carroll Lane
Senior Vice President and
Interim Chief Financial Officer

Date: September 5, 2023




investorpresentationsept
K A M A N I N V E S T O R P R E S E N TAT I O N September 2023


 
2 CAUTIONARY STATEMENT K A M A N . C O M FORWARD LOOKING STATEMENTS This presentation includes "forward looking statements" relating to the announced transactions and future operations of the Company, which can be identified by the use of words such as “will,” “expect,” “poise,” “believe,” “plans,” “strategy,” “prospects,” “estimate,” “project”, “seek,” “target,” “anticipate,” “intend,” “future,” “likely,” “may,” “should,” “would,” “could,” and other words of similar meaning in connection with a discussion of future operating or financial performance or events. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These statements are based on assumptions currently believed to be valid but involve significant risks and uncertainties, many of which are beyond our control, which could cause our actual results to differ from those expressed in the forward looking statements. Such risks and uncertainties include, among others, the ability to implement the anticipated business plans following closing and achieve anticipated benefits and savings; and future and estimated revenues, earnings, cash flow, charges, cost savings and expenditures. Additional risks and uncertainties that could cause our actual results to differ from those expressed in the forward looking statements are identified in our reports filed with the SEC, including our Quarterly Reports on Form 10-Q, our Annual Reports on Form 10-K, and our Current Reports on Form 8-K. The forward looking statements included in this presentation are made only as of the date of this presentation, and the Company does not undertake any obligation to update the forward looking statements to reflect subsequent events or circumstances. NON-GAAP FINANCIAL MEASURES Management believes that the Non-GAAP financial measures (i.e. financial measures that are not computed in accordance with Generally Accepted Accounting Principles) used in this presentation or in other disclosures provide important perspectives into the Company's ongoing business performance. The Company does not intend for the information to be considered in isolation or as a substitute for the related GAAP measures. Other companies may define the measures differently. Reconciliations from GAAP measures to the Non-GAAP measures are presented at the end of the presentation.


 
3K A M A N . C O M $1.2 B ENTERPRISE VALUE 3,000+ EMPLOYEES SALES IN 50+ COUNTRIES 53 CONSECUTIVE YEARS OF DIVIDEND PAYMENTS Note: Data as of June 30, 2023


 
4K A M A N . C O M OUR VISION To propel our customers forward by imagining and delivering highly-engineered solutions


 
5 KEY MESSAGES K A M A N . C O M A FOCUS ON STRATEGIC INITIATIVES TO REDUCE VARIATION IN PERFORMANCE: • Continued strong growth across our Engineered Products portfolio • Consolidation of Precision Products facilities • Discontinuation of K-MAX® and K-MAX® TITAN programs • Right size the total cost structure of the organization FUTURE PERFORMANCE INDICATORS: • Backlog of approximately $700 M with organic backlog increasing ~35% in Engineered Products year-over-year • Robust sales and order activity in medical, industrial, and commercial, business and general aviation markets • Gross margin improvement on higher sales volumes • Refinanced credit agreement; Sufficient capacity to meet future debt obligations and working capital needs


 
6 SEGMENT OUTLOOK & STRATEGY K A M A N . C O M ENGINEERED PRODUCTS Benefit from rebounding commercial aviation market Drive operations excellence PRECISION PRODUCTS STRUCTURES Launch next generation fuzing systems OUTLOOK IMPROVETRANSFORMGROW STRATEGY Win new business Improve new product introduction Develop new products Advance autonomous technologies Win higher margin programs Improve quality and on-time delivery Grow organically and through M&A Pivot to new technologies and markets Strengthen marginMISSION


 
7K A M A N . C O M ENGINEERED PRODUCTS Self Lubricating Bearings Traditional Airframe Bearings Flexible Drive Systems High Precision Miniature Bearings Engine Aftermarket Components High Precision Seals, Springs & Contacts Karon® Self Lubricating Machinable Liner Custom design capability Patented and proprietary technology Proprietary design, machining & assembly FAA parts manufacturing authorization Proprietary design, machining & assembly PROVIDING A BROAD RANGE OF PREMIER PRODUCTS FOR DIVERSE END MARKETS Aircraft Wheel & Brake Proprietary technologies


 
ENGINEERED PRODUCTS K A M A N . C O M 8 • Contribution of sales and margin from Aircraft Wheel & Brake acquisition • Steady strength in commercial aerospace and PMA Aftermarket programs • Sequential increase in sales and gross margin Q2 Key Drivers Q2 2023 Financial Results Net Sales Operating Income Adj. EBITDA Adj. EBITDA Margin $134M $30.5M $40.7M 30.5% Quarterly Results Execute on strong backlog, continue to expand margins and deliver solid results


 
9K A M A N . C O M PRECISION PRODUCTS SAFE & ARM DEVICES Supporting U.S. & Allied militaries Joint Programmable Fuze ATacMS® AMRAAM® Harpoon JASSM® MK54 SLAM-ER Tomahawk DIVERSE AERIAL SYSTEMS Supporting heavy & medium lift applications SH-2G Aftermarket K-MAX® Aftermarket KARGO UAV unmanned aerial system PROVIDING UNMATCHED PRECISION, VERSATILITY AND EFFICIENCY MEMORY & MEASUREMENT Supporting mission & flight critical applications Ruggedized avionics modules Advanced sensor technology Signal Conditioning electronics


 
PRECISION PRODUCTS K A M A N . C O M 10 • Planned lower sales and gross profit for JPF program • Cost growth on legacy fuzing and measuring programs • Lower operating expenses at Orlando facility Q2 Key Drivers Q2 2023 Financial Results Net Sales Operating Income Adj. EBITDA Adj. EBITDA Margin $28.1M $(1.9)M $(1.1)M (3.8)% Quarterly Results Pivot to new technologies and markets


 
11K A M A N . C O M PRECISION PRODUCTS KARGO UAV – UNMANNED AERIAL SYSTEM PURSUING MULTIPLE OPPORTUNITIES WITH RECENT SUCCESS • DEFENSE • Down selected for MULS-A by US Marine Corps • Funding provided for development of prototype • Period of Performance 2023 – 2024 • COMMERCIAL • Partnered with PHI, leading global helicopter solutions provider • Intent to purchase 50 units • Co-develop commercial platform, sales and support model TA R G E T C A PA B I L I T I E S Self-deploys with no payload up to ~500 nautical miles Lifting capacity of 800 lbs Flight testing of full-scale vehicle – 2023 Designed for easy transport and deployment


 
12K A M A N . C O M STRUCTURES PROVIDING KEY STRUCTURAL COMPONENTS ACROSS CRITICAL END MARKETS CH-47 Boeing Chinook refueling probes through 2024 Black Hawk Cockpit Sikorsky multi-year contract awarded in Dec 2021 A-10 Thunderbolt Boeing wing assemblies contract through 2030 Medical Imaging Tables Partnership with Mirion Technologies in Jan 2022 Commercial Engine OEM Outlet Guide Vanes


 
STRUCTURES K A M A N . C O M 13 • Higher sales and margins for composites programs, such as Rolls Royce • Higher sales and associated gross profit on UH-60 program • Receipt of insurance claim settlement Q2 Key Drivers Quarterly ResultsQ2 2023 Financial Results Net Sales Operating Income Adj. EBITDA Adj. EBITDA Margin $34M $(0.1)M $0.7M 2.0% Drive improved quality and performance across segment


 
14 2Q 2023 SALES BY END MARKET K A M A N . C O M BOEING & AIRBUS SALES ~75% OEM CONSOLIDATED SALES: $ 195M ~25% Aftermarket 29% 46% 14% 11% Defense Commercial, Business & General Aviation Medical Industrial & Other


 
K A M A N . C O M 15 PORTFOLIO TRANSFORMATION Divestitures ✓ Kaman Distribution segment ✓ Kaman UK operations ✓ Kaman Mexico structures Acquisitions ✓ Bal Seal Engineering ✓ Investment in Near Earth Autonomy ✓ Aircraft Wheel and Brake Strategic Initiatives ✓ Consolidated Jacksonville facilities ✓ Ceased production of K-MAX ✓ Investment in KARGO UAV ✓ Consolidating JPF production ✓ Reducing costs across the organization REPOSITIONING KAMAN FOR HIGHER GROWTH AND PROFITABILITY


 
FOCUSED ON EXECUTION K A M A N . C O M 16 GROWTH THROUGH INNOVATION Accelerate internal investments in our products, facilities and people OPERATIONAL EXCELLENCE DE-LEVERAGING & CAPITAL ALLOCATION Paydown debt Maintain a disciplined approach to capital allocation Drive significantly improved operating and financial performance EBITDA MARGIN FREE CASH FLOW CONVERSION RETURN ON INVESTED CAPITAL Eliminate sources of variation


 
2023 MARKET OUTLOOK K A M A N . C O M 17 PLATFORM / END MARKETS Safe and Arm Devices Commercial, Business & General Aviation Medical Industrials 2023 vs. 2022 FULL YEAR EXPECTATIONS ↑ ↑ ↑ ↑ Benefiting from strong order rates, improved performance and expansion into new markets Benefiting from strong order rates, improved performance and adoption of new technologies Lower JPF volume Benefiting from strong order rates, improved performance and addition of Aircraft Wheel and Brake Defense Improved performance in defense offerings and addition of Aircraft Wheel and Brake ↑


 


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 19 Adjusted EBITDA and Adjusted EBITDA Margin - Adjusted EBITDA for the consolidated company results is defined as earnings from continuing operations before interest, taxes, other expense (income), net, depreciation and amortization and certain items that are not indicative of the operating performance of the Company for the periods presented. Adjusted EBITDA for the segments is defined as operating income before depreciation and amortization. Adjusted EBITDA margin is defined as Adjusted EBITDA as a percent of Net sales. Management believes Adjusted EBITDA and Adjusted EBITDA margin provide an additional perspective on the operating results of the organization and its earnings capacity and helps improve the comparability of our results between periods because they provide a view of our operations that excludes items that management believes are not reflective of operating performance, such as items traditionally removed from net earnings in the calculation of EBITDA as well as Other expense (income), net and certain items that are not indicative of the operating performance of the Company for the period presented. Adjusted EBITDA and Adjusted EBITDA margin are not presented as an alternative measure of operating performance, as determined in accordance with GAAP. Adjusted Earnings from Continuing Operations and Adjusted Diluted Earnings Per Share - Adjusted earnings from continuing operations and adjusted diluted earnings per share are defined as GAAP “Earnings from continuing operations" and "Diluted earnings per share", less items that are not indicative of the operating performance of the business for the periods presented. These items are included in the reconciliation below. Management uses adjusted earnings from continuing operations and adjusted diluted earnings per share to evaluate performance period over period, to analyze the underlying trends in our business and to assess its performance relative to its competitors. We believe that this information is useful for investors and financial institutions seeking to analyze and compare companies on the basis of operating performance. Adjusted Free Cash Flow – Adjusted free cash flow is defined as GAAP “Net cash provided by (used in) operating activities from continuing operations” in a period less “Expenditures for property, plant & equipment” in the same period and any adjustments that are representative of the Company's cash generation or usage in the period. For 2021 we adjusted free cash flow to remove the cash payment made to Bal Seal employees under the retention plan established by the former owners of Bal Seal. Management believes free cash flow from continuing operations and adjusted free cash flow provides an important perspective on our ability to generate cash from our business operations and, as such, that it is an important financial measure for use in evaluating the Company's financial performance. Free cash flow and adjusted free cash flow should not be viewed as representing the residual cash flow available for discretionary expenditures such as dividends to shareholders or acquisitions, as it may exclude certain mandatory expenditures such as repayment of maturing debt and other contractual obligations. Management uses free cash flow and Adjusted free cash flow internally to assess overall liquidity.


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 20


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 21


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 22


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 23


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 24


 
NON-GAAP RECONCILIATIONS K A M A N . C O M 25